Mode
Text Size
Log in / Sign up
N/A Completed N=1,422 Randomized Double-blind Screening

Digital Outreach Intervention for Lung Cancer Screening

Source: ClinicalTrials.gov NCT04083859 ↗
Enrolled (actual)
1,422
Serious AEs
0.0%
Results posted
Jan 2025
Primary outcomePrimary: Number of Participants With Electronic Health Record-verified Completion of a Chest CT Scan — 164; 113 Participants

Summary

mPATH-Lung (mobile Patient Technology for Health - Lung) is an innovative digital outreach program that identifies patients who qualify for lung cancer screening and helps them get screened. The study will: 1) Determine the effect of mPATH-Lung on receipt of lung cancer screening in a pragmatic randomized-controlled trial conducted with primary care patients in two large health networks, 2) Elucidate the drivers of patients' screening decisions and screening behavior; and 3) Explore implementation outcomes that will impact the sustainability and dissemination of mPATH-Lung using program data, surveys, and interviews. This project will determine how mPATH-Lung affects patients' screening decisions and their completion of screening.

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants With Electronic Health Record-verified Completion of a Chest CT Scan
164; 113 —
SECONDARY
LCS Screening Decision
— —
SECONDARY
Proportion of Patients With LCS Clinic Visits Scheduled
— —
SECONDARY
Proportion of Patients With LCS Clinic Visits Completed
— —
SECONDARY
Proportion of Patients With LCS Scans Ordered
— —
SECONDARY
LCS Clinic Referral Requested Through mPATH
— —
SECONDARY
Lung Cancer Screening Test Results
— —
SECONDARY
Number of LCS False Positives
— —
SECONDARY
Invasive Procedures Following LCS Scan
— —
SECONDARY
Proportion of Patients With Complications Following LCS
— —
SECONDARY
Number of Diagnosed Lung Cancers
— —
SECONDARY
How Diagnosed Lung Cancers Were Detected
— —
SECONDARY
Stage of Lung Cancers Diagnosed
— —
SECONDARY
Overscreening
— —
SECONDARY
Reach of Digital Outreach Strategy
3267 —
SECONDARY
Completion of mPATH-Lung Program
— —

Eligibility Criteria

Inclusion Criteria

  • Meet the Medicare criteria for lung cancer screening, as updated in February 2022:
  • Age 50 - 77 years
  • Smoked at least 20 pack years
  • Current smoker or quit smoking within the past 15 years
  • Be scheduled to see a primary care provider within the health network in the next 3-4 weeks
  • Have a patient portal account or cellphone number listed in the electronic health record

Exclusion Criteria

  • Patients flagged as needing a language interpreter in the electronic health record (electronic messages and intervention is delivered in English only).
  • Those for whom lung cancer screening would be inappropriate:
  • Prior history of lung cancer
  • Chest CT within the last 12 months
  • Those with medical conditions predicting shorter life expectancy
  • Patients whose home address is not within the state of North Carolina. (Due to telehealth guidelines)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT04083859). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search